Date: April 27-30
Location: Barcelona, Spain
Attending
- Laurie Sarrat, Business Development Manager
- Helen Box, Business Development Executive
- Nadir Bessila, Senior Manager Business Development | Anti-Infectives
- Pia Thommes, VP Anti-Infectives
- Francesca Bernardini, VP In vitro Biology
- Isabelle Erbetti, Senior Manager In Vitro Biology
- Hugh Watson, Principal Manager of Clinical Development
- Aurelie Couturier, Group Leader Anti-Infectives
Evotec will be presenting
Session type: Poster Session
Poster number: P0218
Session title: 1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Abstract Title: Prospective evaluation of serum cytokines and musculoskeletal ultrasound as surrogate markers for chronic post-Chikungunya rheumatism
Presenter: Hugh Watsons, Principal Manager of Clinical Development
Date and Time: April 27, 12:00
Location: in Poster Area
|
Session type: Poster Session
Poster number: P2360
Session title: 5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Abstract Title: Assessment of zosurabalpin activity in combination with other antibiotics
Presenter: Isabelle Erbetti, Senior Manager In Vitro Biology
Date and Time: April 28, 12:00
Location: in Poster Area
|
ESPRI-IOAC will be presenting
Session title: Basic science studies using Omics (in vitro and in vivo)
Abstract Title: Bacterial transcriptomics in staphylococcal bone and joint infections: translational experiments from exponential in vitro culture to in vivo infection
Date and Time: April 30th, 12.00
|
Learn more about ECCMID